TNF and cancer: Combination cancer therapy with KD showed decreased expression of COX-2 and pro-inflammatory cytokines, such as tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ), and ILs including IL-1β) via inhibition of NF-κB [169,172].